Search This Blog

Wednesday, March 4, 2020

AMAG Pharmaceuticals EPS of -$5.89

AMAG Pharmaceuticals (NASDAQ:AMAG): Q4 EPS of -$5.89 may not be comparable to consensus of -$0.56.
Revenue of $89.71M (+1.8% Y/Y) beats by $1.16M.
Press Release
https://seekingalpha.com/news/3548463-amag-pharmaceuticals-eps-of-5_89
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)